Back to Search Start Over

Palatin Technologies reports presentation of preclinical data on diabetic nephropathy

Source :
M2 Pharma. May 30, 2023
Publication Year :
2023

Abstract

M2 PHARMA-May 30, 2023-Palatin Technologies reports presentation of preclinical data on diabetic nephropathy (C)2023 M2 COMMUNICATIONS Palatin Technologies (NYSE American: PTN), a biopharmaceutical company focused on developing receptor-specific product candidates [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
M2 Pharma
Publication Type :
News
Accession number :
edsgcl.751147277